ClinConnect ClinConnect Logo
Search / Trial NCT05340738

AI-Based Fidelity Feedback to Enhance CBT

Launched by UNIVERSITY OF PENNSYLVANIA · Apr 15, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Depression Cognitive Behavioral Therapy Therapy Evidence Based Psychotherapy Training Community Mental Health Cbt Fidelity Anxiety

ClinConnect Summary

This clinical trial is studying a new technology called LyssnCBT, which aims to improve the quality of Cognitive Behavioral Therapy (CBT) provided to patients by therapists in community mental health settings. Researchers from the University of Pennsylvania and the technology company Lyssn.io, Inc. want to see if using this technology can help therapists provide better therapy compared to the usual methods. The trial will first test the technology in five mental health agencies to understand any challenges in using it before comparing its effectiveness to standard services.

To participate in this study, therapists must work at a community mental health center in Philadelphia, be able to conduct therapy sessions in English, and agree to have their sessions recorded for research purposes. Clients who receive therapy must also speak English and be willing to allow the research team to collect data from their sessions. Participants can expect to be part of a project that aims to enhance the quality of mental health care, helping both therapists and clients improve their therapy experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Therapists
  • Able to participate in therapy sessions conducted in English
  • Employed at a Philadelphia CMH treatment center that allows the recruitment and participation of therapists in research-related activities
  • Willing to allow their session recordings to be used for research purposes
  • Computer and internet access
  • Supervisors
  • Oversee participating therapists
  • Computer and internet access
  • Clients
  • Able to participate in therapy sessions conducted in English
  • Willing to allow the team to collect data and use their session recordings for research purposes
  • Exclusion Criteria:
  • Unwilling to allow the research team to access their therapy session recordings

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Torrey A Creed, PhD

Principal Investigator

Director, The Penn Collaborative for CBT and Implementation Science

David Atkins, PhD

Principal Investigator

CEO, Lyssn

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials